FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550164051> ?p ?o ?g. }

• W2550164051 endingPage "66" @default.
• W2550164051 startingPage "61" @default.
• W2550164051 abstract "Abstract Objectives: Many advances have been made in the diagnosis, treatment, and management of myasthenia gravis (MG) and most patients will eventually progress to experience minimal manifestations (MM) of the disease or remission. However, there is a paucity of literature on medication dosing needed to achieve such a favorable clinical status in the long term. The objective of this article was to (1) study the course of MG and identify clinical predictors of maintenance of eventual disease remission or minimal manifestations and (2) determine if patients on low-dose medications have comparable MG Foundation of America (MGFA) scores and postintervention statuses (PIS) with those on conventional therapeutic dosing. Methods: This is a retrospective longitudinal chart review of 74 patients with MG. A subset of 28 of 74 patients diagnosed with MG after 2000 who were followed for at least 3 consecutive years from the year of diagnosis were also analyzed. An annual MGFA score, PIS, medication doses, and thymectomy status were obtained. Remission or MM of disease was defined as MGFA clinical classification <2 that persisted over the past 2 follow-up visits. Results: Thirty-four of 74 patients were on low-dose medications at last follow-up. There was no statistical difference between medication dosages and MGFA scores. In a subset of 28 patients, 23 (88.5%) with eventual disease remission or MM at last follow-up had an MGFA class <2 at their third year of diagnosis. In contrast, only 3 of 9 subjects with more symptomatic disease had similar results ( P = 0.005). In terms of PIS at last follow-up, most patients were either in complete stable remission, pharmacologic remission, or MM status. Most patients (78.3%) had an MGFA class of 0 or 1 at last follow-up; 45% were on low-dose medications. Conclusions: Most patients with MG will realize disease stability characterized by either remission or MM status. A significant number of such patients were able to be maintained on low doses of medications to treat MG. The MGFA class at year 3 of diagnosis is a clinical predictor of long-term disease prognosis. There was no statistical difference between medication doses and MGFA scores at last follow-up." @default.
• W2550164051 created "2016-11-30" @default.
• W2550164051 creator A5026264965 @default.
• W2550164051 creator A5033859874 @default.
• W2550164051 creator A5067775440 @default.
• W2550164051 creator A5076353519 @default.
• W2550164051 creator A5087386592 @default.
• W2550164051 date "2016-12-01" @default.
• W2550164051 modified "2023-09-25" @default.
• W2550164051 title "Low-Dose Medication and Long-Term Outcome in Myasthenia Gravis" @default.
• W2550164051 cites W133322506 @default.
• W2550164051 cites W1984685847 @default.
• W2550164051 cites W1998985380 @default.
• W2550164051 cites W2018829962 @default.
• W2550164051 cites W2021083985 @default.
• W2550164051 cites W2041047359 @default.
• W2550164051 cites W2066717363 @default.
• W2550164051 cites W2067776775 @default.
• W2550164051 cites W2073766698 @default.
• W2550164051 cites W2079253050 @default.
• W2550164051 cites W2089117937 @default.
• W2550164051 cites W2091123058 @default.
• W2550164051 cites W2094079385 @default.
• W2550164051 cites W2105642245 @default.
• W2550164051 cites W2109351747 @default.
• W2550164051 cites W2119243846 @default.
• W2550164051 cites W2167873595 @default.
• W2550164051 cites W2462881781 @default.
• W2550164051 cites W4250520649 @default.
• W2550164051 doi "https://doi.org/10.1097/cnd.0000000000000122" @default.
• W2550164051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27861217" @default.
• W2550164051 hasPublicationYear "2016" @default.
• W2550164051 type Work @default.
• W2550164051 sameAs 2550164051 @default.
• W2550164051 citedByCount "8" @default.
• W2550164051 countsByYear W25501640512017 @default.
• W2550164051 countsByYear W25501640512019 @default.
• W2550164051 countsByYear W25501640512020 @default.
• W2550164051 countsByYear W25501640512021 @default.
• W2550164051 countsByYear W25501640512022 @default.
• W2550164051 crossrefType "journal-article" @default.
• W2550164051 hasAuthorship W2550164051A5026264965 @default.
• W2550164051 hasAuthorship W2550164051A5033859874 @default.
• W2550164051 hasAuthorship W2550164051A5067775440 @default.
• W2550164051 hasAuthorship W2550164051A5076353519 @default.
• W2550164051 hasAuthorship W2550164051A5087386592 @default.
• W2550164051 hasConcept C126322002 @default.
• W2550164051 hasConcept C162156334 @default.
• W2550164051 hasConcept C187212893 @default.
• W2550164051 hasConcept C2777288759 @default.
• W2550164051 hasConcept C2778105408 @default.
• W2550164051 hasConcept C2779134260 @default.
• W2550164051 hasConcept C71924100 @default.
• W2550164051 hasConceptScore W2550164051C126322002 @default.
• W2550164051 hasConceptScore W2550164051C162156334 @default.
• W2550164051 hasConceptScore W2550164051C187212893 @default.
• W2550164051 hasConceptScore W2550164051C2777288759 @default.
• W2550164051 hasConceptScore W2550164051C2778105408 @default.
• W2550164051 hasConceptScore W2550164051C2779134260 @default.
• W2550164051 hasConceptScore W2550164051C71924100 @default.
• W2550164051 hasIssue "2" @default.
• W2550164051 hasLocation W25501640511 @default.
• W2550164051 hasLocation W25501640512 @default.
• W2550164051 hasOpenAccess W2550164051 @default.
• W2550164051 hasPrimaryLocation W25501640511 @default.
• W2550164051 hasRelatedWork W2004055883 @default.
• W2550164051 hasRelatedWork W2036334012 @default.
• W2550164051 hasRelatedWork W2059282767 @default.
• W2550164051 hasRelatedWork W2068377708 @default.
• W2550164051 hasRelatedWork W2138660411 @default.
• W2550164051 hasRelatedWork W2160515228 @default.
• W2550164051 hasRelatedWork W2324954285 @default.
• W2550164051 hasRelatedWork W2433073069 @default.
• W2550164051 hasRelatedWork W2947337648 @default.
• W2550164051 hasRelatedWork W4200558499 @default.
• W2550164051 hasVolume "18" @default.
• W2550164051 isParatext "false" @default.
• W2550164051 isRetracted "false" @default.
• W2550164051 magId "2550164051" @default.
• W2550164051 workType "article" @default.